XML 28 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows      
Cash and cash equivalents $ 18,761 [1] $ 20,066 [1] $ 29,619
Restricted cash 27,979 [1] 28,324 [1] 8,897
Total cash and cash equivalents and restricted cash 46,740 48,390 38,516
Supplemental disclosure of cash flow information:      
Cash paid for interest 151,263 93,853 59,034
Supplemental disclosure of non-cash investing and financing activity:      
Debt obligations assumed (refer to Note 3) 99,995    
Issuance of common stock for acquisition of assets (refer to Note 3) 35,588    
Non-cash interest accrued to debt balances 4,055 1,988  
Dividends declared to common shareholders 13,033 11,050 9,647
Accrued finance costs   $ 54 89
Accrued offering costs $ 64   50
Caret Unit conversion (refers to Note 11)     $ 747
[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities ("VIEs").